Literature DB >> 30623359

Biological Products: Cellular Therapy and FDA Approved Products.

Ali Golchin1, Tahereh Zarnoosheh Farahany2.   

Abstract

The pace of advances in the world of science have created new opportunities and insights that give us new and more understanding of our nature and environment. Among the different fields of science, new medical sciences have drawn a great deal of attention among medical science researchers and the society. The hope for finding treatments for incurable diseases and further improvement of man's health is growing thanks to new medical technologies. Among the novel medical fields that have been extensively covered by medical and academic societies are cell therapy and gene therapy that are categorized under regenerative medicine. The present paper is an attempt to introduce the prospect of a curative cell-based therapy and new cellular and gene therapy drugs that have been recently approved by FDA (food and drug administration). Cellular and gene therapy are two very close fields of regenerative medicine and sciences which their targets and applications can be discussed together. What adds to the importance of this new field of science is the possibility to translate the hope for treatment of incurable diseases into actual treatments. What follows delves deeper into this new field of science and the drugs.

Entities:  

Keywords:  Applications; Approved drugs; Cellular therapy; Gene therapy; Stem cell

Year:  2019        PMID: 30623359     DOI: 10.1007/s12015-018-9866-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  55 in total

1.  Recent advances in the therapy of castration-resistant prostate cancer: the price of progress.

Authors:  Dhwanishiva Vasani; David Y Josephson; Courtney Carmichael; Oliver Sartor; Sumanta Kumar Pal
Journal:  Maturitas       Date:  2011-08-09       Impact factor: 4.342

2.  A pilot study to evaluate a tissue-engineered bilayered cell therapy as an alternative to tissue from the palate.

Authors:  Michael K McGuire; E Todd Scheyer; Martha E Nunn; Philip T Lavin
Journal:  J Periodontol       Date:  2008-10       Impact factor: 6.993

3.  FDA approves first cell therapy for wrinkle-free visage.

Authors:  Charles Schmidt
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

4.  Method for somatic cell nuclear transfer in zebrafish.

Authors:  Kannika Siripattarapravat; Jose B Cibelli
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

5.  Patellofemoral full-thickness chondral defects treated with Hyalograft-C: a clinical, arthroscopic, and histologic review.

Authors:  Alberto Gobbi; Elisaveta Kon; Massimo Berruto; Ramces Francisco; Giuseppe Filardo; Maurilio Marcacci
Journal:  Am J Sports Med       Date:  2006-07-10       Impact factor: 6.202

6.  Remodeling of articular cartilage and subchondral bone after bone grafting and matrix-associated autologous chondrocyte implantation for osteochondritis dissecans of the knee.

Authors:  Björn Gunnar Ochs; Christian Müller-Horvat; Dirk Albrecht; Bernhard Schewe; Kuno Weise; Wilhelm Karl Aicher; Bernd Rolauffs
Journal:  Am J Sports Med       Date:  2010-12-30       Impact factor: 6.202

Review 7.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

8.  PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

Authors:  Martin A Cheever; Celestia S Higano
Journal:  Clin Cancer Res       Date:  2011-04-06       Impact factor: 12.531

9.  Autologous fibroblast culture in the repair of aging skin.

Authors:  Lilian Piñero Eça; Débora Galdino Pinto; Ariene Murari Soares de Pinho; Marcelo Paulo Vaccari Mazzetti; Marina Emiko Yagima Odo
Journal:  Dermatol Surg       Date:  2011-10-10       Impact factor: 3.398

Review 10.  A review of a bi-layered living cell treatment (Apligraf) in the treatment of venous leg ulcers and diabetic foot ulcers.

Authors:  Larissa Zaulyanov; Robert S Kirsner
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more
  30 in total

Review 1.  Advances in translational orthopaedic research with species-specific multipotent mesenchymal stromal cells derived from the umbilical cord.

Authors:  Melina Ramallo; Irene Carreras-Sánchez; Alba López-Fernández; Roberto Vélez; Màrius Aguirre; Sara Feldman; Joaquim Vives
Journal:  Histol Histopathol       Date:  2020-09-11       Impact factor: 2.303

Review 2.  Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.

Authors:  Yinan Xiao; Hanyue Xu; Wen Guo; Yunuo Zhao; Yuling Luo; Ming Wang; Zhiyao He; Zhenyu Ding; Jiyan Liu; Lei Deng; Fushen Sha; Xuelei Ma
Journal:  Mol Biomed       Date:  2020-12-03

Review 3.  How to establish infrastructures to achieve more efficient regenerative medicine?

Authors:  Babak Arjmand; Bagher Larijani; Sepideh Alavi-Moghadam; Hamid Reza Aghayan; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Mahmood Biglar; Mohsen Rajaeinejad; Fatemeh Fazeli Shouroki
Journal:  Cell Tissue Bank       Date:  2022-07-24       Impact factor: 1.752

Review 4.  Strategies for Testing Intervention Matching Schemes in Cancer.

Authors:  Nicholas J Schork; Laura H Goetz; James Lowey; Jeffrey Trent
Journal:  Clin Pharmacol Ther       Date:  2020-07-24       Impact factor: 6.875

5.  Immune-Based Therapy for COVID-19.

Authors:  Abdolreza Esmaeilzadeh; Davood Jafari; Safa Tahmasebi; Reza Elahi; Elnaz Khosh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Stem Cell Therapy Potency in Personalizing Severe COVID-19 Treatment.

Authors:  Arefeh Basiri; Fatemeh Mansouri; Arezo Azari; Parviz Ranjbarvan; Fateme Zarein; Arash Heidari; Ali Golchin
Journal:  Stem Cell Rev Rep       Date:  2021-01-28       Impact factor: 5.739

Review 7.  Cell augmentation strategies for cardiac stem cell therapies.

Authors:  Raquel Cruz-Samperio; Millie Jordan; Adam Perriman
Journal:  Stem Cells Transl Med       Date:  2021-03-04       Impact factor: 6.940

Review 8.  Engineering microenvironments for manufacturing therapeutic cells.

Authors:  Brian J Kwee; Kyung E Sung
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-11

9.  Engineering reversible cell-cell interactions using enzymatically lipidated chemically self-assembled nanorings.

Authors:  Yiao Wang; Ozgun Kilic; Clifford M Csizmar; Sudhat Ashok; James L Hougland; Mark D Distefano; Carston R Wagner
Journal:  Chem Sci       Date:  2020-10-26       Impact factor: 9.825

Review 10.  Multifunctional Scaffolds and Synergistic Strategies in Tissue Engineering and Regenerative Medicine.

Authors:  Nicolas Muzzio; Sergio Moya; Gabriela Romero
Journal:  Pharmaceutics       Date:  2021-05-26       Impact factor: 6.525

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.